All In MedTech

Device Trial Radar · NCT03654066

Botox or Botox With Esophageal Dilation in Patients With Achalasia

Prospective Single-Blinded Randomized Controlled Trial Comparing Botox or Botox With Esophageal Dilation in Patients With Achalasia

Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

9

Actual

Start

May 13, 2019

Primary completion

Jun 1, 2026

Study completion Aug 1, 2026

Sponsor

Lead sponsor
Vanderbilt University Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 31, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Achalasia is a rare esophageal motility disorder. Treatment of achalasia is aimed toward palliation of symptoms. These include botox injections to the lower esophageal sphincter (LES), pneumatic dilation, surgical myotomy, and per-oral endoscopic myotomy (POEM). Botox injections are frequently used for patients that have significant comorbidities. The primary aim of this study is to assess symptomatic response of patient with achalasia to esophageal dilation and botox injection to the LES compared to standard therapy of only botox injection.

Conditions

  • Achalasia

Interventions

  • Botulinum toxin type ADrug

    Botox injection in the LES

  • Endoscope balloon dilatorDevice

    Distal esophageal dilation

  • Patient reported outcomesOther

    Subjects will complete two patient reported outcome measures (Eckardt and MADS).

  • Barium esophagramDiagnostic test

    Assess for radiologic severity of achalasia with barium column height measured 1 minute and 5 minutes after upright ingestion of barium

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. dysphagia scoreTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vanderbilt University Medical Center Endoscopy Laboratory

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.